Skip to main content
Recall Canary
Trokendi XR Topiramate ER Capsules 25mg
← Back to all recalls
DRUG RECALLLOW

Trokendi XR Topiramate ER Capsules 25mg

Supernus recalls Trokendi XR 25mg capsules over failed dissolution specs.

What to do

Check your prescription bottle for NDC 17772-101-30. If you have the affected product, stop taking it and contact your pharmacist or healthcare provider for a replacement. Return any unused capsules to the pharmacy.

Recalled
Listed
Updated
Recall No.
N/A
Agency
FDA
Firm
Supernus Pharmaceuticals, Inc.
Recall ID
99375
Status
ONGOING

Recall at a glance

Quantity recalled
15,853 bottles

Why it was recalled

Supernus Pharmaceuticals is recalling Trokendi XR (topiramate) extended-release capsules, 25 mg, 30-count bottles, due to failed dissolution specifications. The affected product may not release the medication as intended, potentially reducing its effectiveness.

Is mine affected?

Check the NDC or UPC and strength printed on the package. Yours is affected if it matches one below.

Trokendi XR, topiramate extended-release capsulesLot code: 2075801, 31-Oct-2029Strength: 25 mgNDC / UPC: NDC 17772-101-30

Recall #
N/A
D-0758-2026

Where it was sold

Distributed nationwide.

Timeline

  1. Firm initiated recall
  2. Publicly announced
  3. Listed on Recall Canary
  4. Summary updated

Official source

View on U.S. Food and Drug Administration →

Other Dissolution Failure recalls

Other recent recalls from Supernus Pharmaceuticals, Inc.

All recalls from Supernus Pharmaceuticals, Inc.

← Back to all recalls

Editorial summary by Recall Canary · summary updated 2026-08-12 · primary source: U.S. Food and Drug Administration · severity reflects the agency's published classification